What types of malignant diseases are Mitotane mainly used to treat?

Mitotane is a drug specifically used to treat certain types of endocrine system malignancies, mainly adrenocortical carcinoma (Adrenocortical carcinoma, ACC). Adrenocortical carcinoma is a rare but aggressive malignancy that originates from adrenocortical cells and is often associated with excessive secretion of corticosteroid hormones. Mitotane has become an important drug in the treatment of this disease by inhibiting the function of the adrenal cortex and directly killing tumor cells.

In clinical practice, mitotane is not only used for patients with advanced or unresectable adrenocortical cancer, but is also often used as an adjuvant treatment for adjuvant chemotherapy after surgical resection to reduce the risk of recurrence. Due to the aggressive nature and high recurrence rate of adrenocortical cancer, the use of mitotane helps prolong patient survival and improve quality of life. In addition, mitotane can be used to control excessive hormone secretion by tumors, thereby alleviating related clinical symptoms, such as Cushing's syndrome.

Although the primary indication for mitotane is adrenocortical cancer, in certain special circumstances clinicians may also explore its potential use in other adrenal-related malignancies. However, such applications are still in the research or clinical trial stage and have not yet become routine treatments. Therefore, the use of mitotane should strictly follow the doctor's instructions and be combined with the patient's specific condition and treatment response.

In general, mitotane is an important drug for the treatment of adrenocortical cancer, acting by inhibiting adrenal gland function and directly killing tumor cells. Its unique mechanism of action and clinical value make it an irreplaceable choice in the treatment of this disease. In the future, with the deepening of research, the application scope and efficacy of mitotane are expected to be further expanded.

Reference materials:https://go.drugbank.com/drugs/DB00648